Correlation Between Prime Medicine, and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and ATyr Pharma, you can compare the effects of market volatilities on Prime Medicine, and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and ATyr Pharma.
Diversification Opportunities for Prime Medicine, and ATyr Pharma
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Prime and ATyr is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and ATyr Pharma go up and down completely randomly.
Pair Corralation between Prime Medicine, and ATyr Pharma
Given the investment horizon of 90 days Prime Medicine, Common is expected to generate 0.56 times more return on investment than ATyr Pharma. However, Prime Medicine, Common is 1.79 times less risky than ATyr Pharma. It trades about -0.04 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.04 per unit of risk. If you would invest 806.00 in Prime Medicine, Common on August 27, 2024 and sell it today you would lose (486.00) from holding Prime Medicine, Common or give up 60.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 53.23% |
| Values | Daily Returns |
Prime Medicine, Common vs. ATyr Pharma
Performance |
| Timeline |
| Prime Medicine, Common |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Prime Medicine, and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine, and ATyr Pharma
The main advantage of trading using opposite Prime Medicine, and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |